Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphocele × Octreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 11 Neoplasms 8 Diarrhea 6 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 6 Carcinoid Tumor 6 Breast Neoplasms 5 Vipoma 4 Stomach Neoplasms 4 Somatostatinoma 4 Rectal Neoplasms 4 Insulinoma 4 Glucagonoma 4 Esophageal Neoplasms 4 Carcinoma, Islet Cell 4 Adenoma, Islet Cell 4 Weight Loss 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Intestinal Obstruction 3 Gastro-enteropancreatic neuroendocrine tumor 3 Gastrinoma 3 Colonic Neoplasms 3 Carcinoma 3 Acromegaly 3 Thymoma 2 Ovarian Neoplasms 2 Meningioma 2 Malnutrition 2

Interventions

Standard of Care 1 Sclerotherapy 1 Prostatectomy 1 Octreotide 1 Fibrin Tissue Adhesive 1 Fenestration, Labyrinth 1 Drainage 1 Cisplatin 1 Bandages 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated

Breast Neoplasms, Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon ⚡